Healthcare


 Actinogen gets upbeat results from Xanamem trial for Alzheimer’s treatment

Actinogen gets upbeat results from Xanamem trial for Alzheimer’s treatment

April 27, 2022 07:28 PM AEST| By Aditi Sarkar

Highlights Actinogen Medical receives encouraging results for XanaMIA Part A trial for its lead compound Xanamem The results confirm the potential of Xanamem to improve cognition even in a cognitively normal population Xanamem exhibited a good.....

 Jatcorp (ASX: JAT) reports strong revenue growth in March quarter

Jatcorp (ASX: JAT) reports strong revenue growth in March quarter

April 26, 2022 07:42 PM AEST| By Aditi Sarkar

Highlights The ease in pandemic restrictions has put Jatcorp in an excellent position to reap the benefits of investments made since 2020 The company’s gross revenue for the March quarter increased by 25% and 87% compared to the December...

 PolyNovo (ASX:PNV) charged up on record revenue in March quarter

PolyNovo (ASX:PNV) charged up on record revenue in March quarter

April 06, 2022 06:25 PM AEST| By Sonal Goyal

Highlights PolyNovo has delivered a return of AU$12.26 million in the March quarter. Proceeds for the Lorimer Street property sale is expected in July 2022. PolyNovo’s clinical trial programme is also on track. Shares of PolyNovo Li.....

 ACW, IHL & CGS: ASX healthcare penny stocks with over 150% returns in one year

ACW, IHL & CGS: ASX healthcare penny stocks with over 150% returns in one year

April 06, 2022 02:56 PM AEST| By Aditi Sarkar

Highlights Penny stocks have strong potential to yield lucrative rewards. They are extremely volatile; thus, investors should do proper due diligence. ACW, IHL and CGS are among the penny stocks from the ASX healthcare space that have delivere.....

 MX1, MDR, and OSX: Medical technology stocks from ASX

MX1, MDR, and OSX: Medical technology stocks from ASX

April 06, 2022 12:43 PM AEST| By Aditi Sarkar

Highlights Products, services, and solutions used in the medical field are known as medical technologies Pregnancy tests and X-rays are one of the widely used medical technologies The rapid advancement of technology has resulted in sophisticat.....

 BGH intends to make new Virtus (ASX:VRT) bid at AU$8 cash per share

BGH intends to make new Virtus (ASX:VRT) bid at AU$8 cash per share

April 06, 2022 11:54 AM AEST| By Priyanka Payal

Highlights BGH Capital is considering making an off-market takeover offer to acquire all fully paid ordinary shares (Shares) in Virtus Health Limited at AU$8.00 cash per share. The renewed bid comes after Virtus had already recommended a takeov.....

 All you need to know about the S&P/ASX 200 Health Care

All you need to know about the S&P/ASX 200 Health Care

April 05, 2022 01:58 PM AEST| By Aditi Sarkar

Highlights Indices are benchmark and a standard reference point for the entire stock market Comparison with an index gives an easy assessment of a stock’s performance The S&P/ASX200 index has provided the highest total return in 2012.....

 What about the Cyber Security bill is ailing private hospitals?

What about the Cyber Security bill is ailing private hospitals?

April 04, 2022 12:50 PM AEST| By Aditi Sarkar

Highlights According to the new Cyber Security Bill proposed in Australia, private hospitals with Intensive Care Units must comply with cyber security obligations Private hospitals are having difficulty in complying with new security measures d.....

 Anatara Life Sciences (ASX: ANR) swiftly progresses its clinical trials

Anatara Life Sciences (ASX: ANR) swiftly progresses its clinical trials

April 01, 2022 07:25 PM AEDT| By Aditi Sarkar

Highlights Anatara Lifesciences is advancing well in its clinical trials in psychological functioning and irritable bowel syndrome, diarrhoea subtype (IBS-D) The business prospect for non-prescription gastrointestinal disorders and IBS is US$8 .....

 PCK, LBT, OPL – Three AI stocks from ASX healthcare

PCK, LBT, OPL – Three AI stocks from ASX healthcare

April 01, 2022 05:52 PM AEDT| By Aditi Sarkar

Highlights Integrating AI into medical sector can enhance different processes like medical screenings, diagnosis, and patient data Cardiology, neurology, and cancer are the major diseases that utilise AI tools AI delivers data for diagnosis, t.....

 How have REG, CSL share prices fared after budget’s healthcare boost?

How have REG, CSL share prices fared after budget’s healthcare boost?

March 31, 2022 11:22 AM AEDT| By Ashish

Highlights ASX-listed healthcare stocks have gained after the budget presentation. The stocks received a significant boost from extra spending on Medicare announced in the budget. The Australian Federal Budget was tabled on 29 March...

 Polynovo (ASX:PNV) shows uptrend after shedding 58% in a year

Polynovo (ASX:PNV) shows uptrend after shedding 58% in a year

March 30, 2022 04:25 PM AEDT| By Samta

Highlights Polynovo shares have been gaining attention despite no new announcement. The stock that dropped over 58% in the last 12 months, has been displaying an upward momentum this week. PNV's second quarter US sales grew 105% on pcp in the .....

 Living Cell (ASX:LCT) surges over 14% on clinical trial for Parkinson's disease

Living Cell (ASX:LCT) surges over 14% on clinical trial for Parkinson's disease

March 30, 2022 03:38 PM AEDT| By Aditi Saha

Highlights LCT has inked a deal with University of Technology to utilise university facilities in Sydney. NTCELL capsules will be manufactured in Australia for the first time, progressing the third clinical trial of NTCELL in Parkinson’s .....

 Telix (ASX:TLX) shares jump on receiving an FDA approval

Telix (ASX:TLX) shares jump on receiving an FDA approval

March 29, 2022 07:08 PM AEDT| By Aditi Saha

Highlights Telix has been granted an FDA approval for Orphan Drug Designation for bone marrow conditioning treatment. Telix is a biopharmaceutical business specialising in commercialising and producing therapeutic and diagnostic products. The .....

 CapVest Partners gets approval from FIRB to takeover Virtus Health (ASX:VRT)

CapVest Partners gets approval from FIRB to takeover Virtus Health (ASX:VRT)

March 25, 2022 08:52 PM AEDT| By Aditi Saha

Highlights CapVest Partners has received confirmation from FIRB to buy Virtus Health. This follows an announcement by the company on 14 March 2022. Virtus Health Limited specialises in the business of fertility, medical day procedures, and med.....

 Incannex (ASX: IHL) signs term sheet to snap up APIRx Pharmaceutical USA

Incannex (ASX: IHL) signs term sheet to snap up APIRx Pharmaceutical USA

March 24, 2022 05:34 PM AEDT| By Aditi Sarkar

A clinical-stage pharmaceutical company, Incannex Healthcare Limited (ASX: IHL) (Nasdaq: IXHL) has executed a term sheet with binding commercial terms to wholly acquire APIRx Pharmaceutical USA, LLC ('APIRx'). The proposed acquisition price is US$9.....

 ASX food and beverage stocks with highest 52-week return - GNC, LRK and RIC

ASX food and beverage stocks with highest 52-week return - GNC, LRK and RIC

March 14, 2022 02:04 PM AEDT| By Aditi Sarkar

The term consumer staples represents a range of essential products used by customers. This group includes things like foods and beverages, household goods, hygiene products, alcohol, and tobacco. The S&P/ASX 200 consumer staples index has gain.....

 From Metcash to Ansell: 5 ASX healthcare mid-cap shares in focus

From Metcash to Ansell: 5 ASX healthcare mid-cap shares in focus

February 16, 2022 01:37 PM AEDT| By Team Kalkine Media

On the Australian Securities Exchange (ASX), mid-cap stocks are the stocks whose market capitalisation ranges from AU$2 billion to AU$10 billion, i.e., these stocks fall between the small-cap and large-cap categories. Mid-cap stocks are favourite .....

 Imugene Secures Option Underwriting Agreement with Bell Potter to Raise $5.7 Million

Imugene Secures Option Underwriting Agreement with Bell Potter to Raise $5.7 Million

September 10, 2020 12:50 PM AEST| By Team Kalkine Media

NSW-headquartered clinical stage immuno-oncology firm, Imugene Limited (ASX:IMU) has secured an underwriting agreement with Bell Potter Securities Limited with institutional investors to underwrite the balance of options not exercised by 30 Novembe.....

 SUDA Secures Australian Patent Office’s Approval on Anagrelide Cancer Patent

SUDA Secures Australian Patent Office’s Approval on Anagrelide Cancer Patent

September 09, 2020 02:17 PM AEST| By Team Kalkine Media

Summary SUDA’s share price soared by ~12% on securing approval for anagrelide cancer patent in Australia. With the Australian Patent Office accepting the patent application, the anagrelide patent will now proceed to grant. The approval o.....

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.